{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T15:00:52Z","timestamp":1784127652241,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.transproceed.2016.04.009","type":"journal-article","created":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T01:17:42Z","timestamp":1472260662000},"page":"2023-2033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Anti-vimentin Antibodies Present at the Time of Transplantation May Predict Early Development of Interstitial Fibrosis\/Tubular Atrophy"],"prefix":"10.1016","volume":"48","author":[{"given":"R.I.","family":"Lopez-Soler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Borgia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kanangat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.L.","family":"Fhied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Constantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2016.04.009_bib1","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","article-title":"The natural history of chronic allograft nephropathy","volume":"349","author":"Nankivell","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2016.04.009_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1681\/ASN.2014040378","article-title":"Through a glass darkly: seeking clarity in preventing late kidney transplant failure","volume":"26","author":"Stegall","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2016.04.009_bib3","first-page":"201","article-title":"Anti-HLA class II antibodies and chronic allograft nephropathy","author":"Gerbase-DeLima","year":"2006","journal-title":"Clin Transpl"},{"key":"10.1016\/j.transproceed.2016.04.009_bib4","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1111\/j.1600-6143.2006.01503.x","article-title":"Post-transplant anti-HLA class II antibodies as risk factor for late kidney allograft failure","volume":"6","author":"Campos","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.04.009_bib5","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.transproceed.2008.02.050","article-title":"Association between the presence of anti-HLA antibodies with acute rejection and chronic allograft nephropathy in the first year after kidney transplantation","volume":"40","author":"Toresan","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.04.009_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOT.0b013e3283342780","article-title":"Antihuman leukocyte antigen antibody-induced autoimmunity: role in chronic rejection","volume":"15","author":"Nath","year":"2010","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2016.04.009_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3904\/kjim.2001.16.1.24","article-title":"Clinical significance of anti-endothelial cell antibody in renal transplant recipients","volume":"16","author":"Shin","year":"2001","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.transproceed.2016.04.009_bib8","first-page":"104","article-title":"Pretransplant detection of anti-endothelial cell antibodies could predict renal allograft outcome","volume":"7","author":"Ismail","year":"2009","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.transproceed.2016.04.009_bib9","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.transproceed.2004.12.043","article-title":"Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation","volume":"37","author":"Carter","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.04.009_bib10","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1016\/j.transproceed.2005.09.062","article-title":"Anti-vimentin antibody detection in recipients of heart-beating and non-heart beating donor kidneys","volume":"37","author":"Mi","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.04.009_bib11","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/01.TP.0000443224.66960.37","article-title":"Role of anti-vimentin antibodies in renal transplantation","volume":"98","author":"Besarani","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.04.009_bib12","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/00007890-200104150-00011","article-title":"Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation","volume":"71","author":"Jurcevic","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.04.009_bib13","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1172\/JCI38339","article-title":"Introducing intermediate filaments: from discovery to disease","volume":"119","author":"Eriksson","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.transproceed.2016.04.009_bib14","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/bies.10140","article-title":"Beyond structure: do intermediate filaments modulate cell signalling?","volume":"24","author":"Paramio","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.transproceed.2016.04.009_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ncb898","volume":"5","author":"Mor-Vaknin","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.transproceed.2016.04.009_bib16","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1128\/JVI.03826-13","article-title":"Cell surface vimentin is an attachment receptor for enterovirus 71","volume":"88","author":"Du","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.transproceed.2016.04.009_bib17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1189\/jlb.0405190","article-title":"Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis","volume":"79","author":"Moisan","year":"2006","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.transproceed.2016.04.009_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1189\/jlb.0607339","article-title":"Vimentin autoantibodies induce platelet activation and formation of platelet-leukocyte conjugates via platelet-activating factor","volume":"83","author":"Leong","year":"2008","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.transproceed.2016.04.009_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.humimm.2008.01.015","article-title":"Positive association of anticytoskeletal endothelial cell antibodies and cardiac allograft rejection","volume":"69","author":"Alvarez-Marquez","year":"2008","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2016.04.009_bib20","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2353\/ajpath.2007.060728","article-title":"Autoantibodies to vimentin cause accelerated rejection of cardiac allografts","volume":"170","author":"Mahesh","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.transproceed.2016.04.009_bib21","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1016\/j.transproceed.2008.08.002","article-title":"C4d deposition is correlated with the level of antivimentin antibody in rat kidneys undergoing chronic allograft nephropathy","volume":"40","author":"Yang","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.04.009_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jim.2014.03.011","article-title":"Development of a bead-based immunoassay to routinely measure vimentin autoantibodies in the clinical setting","volume":"407","author":"Fhied","year":"2014","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.transproceed.2016.04.009_bib23","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.transproceed.2012.11.025","article-title":"Long-term follow-up of non-HLA and anti-HLA antibodies: incidence and importance in renal transplantation","volume":"45","author":"Banasik","year":"2013","journal-title":"Transplant Proc"},{"issue":"1 Suppl","key":"10.1016\/j.transproceed.2016.04.009_bib24","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/01.tp.0000231348.55262.5a","article-title":"Endothelial cells as targets of allograft rejection","volume":"82","author":"Glotz","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.04.009_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00007890-198809000-00005","article-title":"The significance of a donor-specific vessel crossmatch in renal transplantation","volume":"46","author":"Cerilli","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.04.009_bib26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0198-8859(00)00109-9","article-title":"Antibodies eluted from acutely rejected renal allografts bind to and activate human endothelial cells","volume":"61","author":"Lucchiari","year":"2000","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2016.04.009_bib27","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1096\/fj.09-151639","article-title":"Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition","volume":"24","author":"Mendez","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.transproceed.2016.04.009_bib28","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuron.2005.01.023","article-title":"Vimentin-dependent spatial translocation of an activated MAP kinase in injured nerve","volume":"45","author":"Perlson","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.transproceed.2016.04.009_bib29","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jmb.2006.09.056","article-title":"Vimentin binding to phosphorylated Erk sterically hinders enzymatic dephosphorylation of the kinase","volume":"364","author":"Perlson","year":"2006","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.transproceed.2016.04.009_bib30","doi-asserted-by":"crossref","first-page":"29772","DOI":"10.1074\/jbc.M001207200","article-title":"Calyculin A-induced vimentin phosphorylation sequesters 14-3-3 and displaces other 14-3-3 partners in\u00a0vivo","volume":"275","author":"Tzivion","year":"2000","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.transproceed.2016.04.009_bib31","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1038\/onc.2009.119","article-title":"PAK signaling in oncogenesis","volume":"28","author":"Molli","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.transproceed.2016.04.009_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1356-9597.2001.00504.x","article-title":"Phosphorylation and reorganization of vimentin by p21-activated kinase (PAK)","volume":"7","author":"Goto","year":"2002","journal-title":"Genes Cells"},{"key":"10.1016\/j.transproceed.2016.04.009_bib33","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1128\/MCB.18.11.6325","article-title":"RhoA-binding kinase alpha translocation is facilitated by the collapse of the vimentin intermediate filament network","volume":"18","author":"Sin","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.transproceed.2016.04.009_bib34","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/eji.200838884","article-title":"Leukocyte transmigration is modulated by chemokine-mediated PI3Kgamma-dependent phosphorylation of vimentin","volume":"39","author":"Barberis","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.transproceed.2016.04.009_bib35","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1038\/sj.emboj.7600847","article-title":"PKCepsilon-mediated phosphorylation of vimentin controls integrin recycling and motility","volume":"24","author":"Ivaska","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.transproceed.2016.04.009_bib36","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/268240a0","article-title":"Human smooth muscle autoantibodies reacting with intermediate (100 A) filaments","volume":"268","author":"Kurki","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.transproceed.2016.04.009_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-1759(84)90462-9","article-title":"The detection of human antibodies against cytoskeletal components","volume":"67","author":"Kurki","year":"1984","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.transproceed.2016.04.009_bib38","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","article-title":"Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis","volume":"56","author":"Bang","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.transproceed.2016.04.009_bib39","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/annrheumdis-2014-206785","article-title":"Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis","volume":"75","author":"Juarez","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.transproceed.2016.04.009_bib40","first-page":"S188","article-title":"Characterization of endothelial antigens associated with transplant-associated coronary artery disease","volume":"14","author":"Wheeler","year":"1995","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2016.04.009_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/TP.0b013e3181dfa694","article-title":"Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts","volume":"90","author":"Mahesh","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.04.009_bib42","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.humimm.2013.06.014","article-title":"Vimentin antibody production in transplant patients and immunomodulatory effects of vimentin in-vitro","volume":"74","author":"Carter","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2016.04.009_bib43","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/pr900930d","article-title":"Identification of Non-HLA antigens targeted by alloreactive antibodies in patients undergoing chronic hemodialysis","volume":"9","author":"Bilalic","year":"2010","journal-title":"J\u00a0Proteome Res"},{"key":"10.1016\/j.transproceed.2016.04.009_bib44","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1182\/blood-2002-12-3702","article-title":"Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2","volume":"102","author":"Boilard","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2016.04.009_bib45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/ctr.12567","article-title":"Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population","volume":"29","author":"Young","year":"2015","journal-title":"Clin Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516301555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516301555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T19:49:32Z","timestamp":1762026572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134516301555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0041134516301555"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.04.009","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-vimentin Antibodies Present at the Time of Transplantation May Predict Early Development of Interstitial Fibrosis\/Tubular Atrophy","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}